Munc18 Proteins in Airway Mucus Hypersecretion

气道粘液分泌过多中的 Munc18 蛋白

基本信息

  • 批准号:
    6600822
  • 负责人:
  • 金额:
    $ 37.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-04-01 至 2007-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Airway mucus forms a protective layer against inhaled particles and pathogens. However, excessive mucus secretion in response to inflammatory stimuli can lead to airflow obstruction. Mucus hypersecretion can be divided into two distinct stages: metaplasia of an epithelial layer that consists predominantly of ciliated and Clara cells into a layer that consists predominantly of mucus-secreting goblet cells; this is followed by regulated secretion of mucus from the metaplastic epithelium. At a molecular level, secretory metaplasia involves expression of genes encoding three sets of proteins: secretory products; components of an exocytic machinery; and signal transduction pathways connecting extracellular secretory signals to exocytic membrane fusion. Secreted macromolecules and signal transduction pathways are subjects of intensive study, but little is known about the exocytic machinery. Munc18 proteins are ubiquitous components of the exocytic machinery of secretory cells. Their absence leads to a complete failure of secretion, and their overexpression also impairs secretion. Together, these data indicate the critical role played by Munc18 proteins and suggest that their expression is tightly regulated. We have found that Munc18B is highly upregulated in metaplastic airway epithelium of mice, and that its promoter region contains elements known to respond to inflammatory stimuli. We propose to suppress expression of Munc18B to test the protective and pathophysiologic roles of mucus secretion in models of allergic and infectious lung inflammation in mice, and to analyze the control of Munc18B expression in mice and humans to gain insight into the molecular pathogenesis of mucus metaplasia. Aim 1: Further characterize the cellular biology of Munc18 proteins in the regulation of airway mucus secretion in murine and human cells. Aim 2: Analyze the protective and pathophysiologic roles of mucus hypersecretion in murine models of allergic asthma and bacterial pneumonia by reducing the capability of airway goblet cells to secrete mucus through reduction of Munc18B expression. Aim 3: Identify critical cis-acting DNA elements and transcription factors that control expression of the Munc18B gene in metaplastic airway epithelium of mice. Aim 4: Confirm the importance of cis-acting DNA elements and transcription factors that control expression of the Munc18B gene in airway secretory metaplasia of humans.
描述(由申请人提供): 气道粘液形成一层保护层,防止吸入颗粒和病原体。然而,响应于炎症刺激的过度粘液分泌可导致气流阻塞。粘液分泌过多可以分为两个不同的阶段:上皮层的化生,主要由纤毛细胞和克拉拉细胞组成的层,主要由分泌粘液的杯状细胞组成;这是其次是调节分泌的粘液从化生上皮。在分子水平上,分泌性化生涉及编码三组蛋白质的基因的表达:分泌产物;细胞外机制的组分;以及连接细胞外分泌信号与细胞外膜融合的信号转导途径。分泌的大分子和信号转导途径是深入研究的主题,但对胞外机制知之甚少。Munc 18蛋白是分泌细胞的胞吐机制的普遍存在的组分。它们的缺失导致分泌的完全失败,并且它们的过表达也损害分泌。总之,这些数据表明Munc 18蛋白发挥的关键作用,并表明它们的表达受到严格调控。我们发现Munc 18 B在小鼠气道上皮化生中高度上调,其启动子区含有已知对炎症刺激有反应的元件。我们建议抑制Munc 18 B的表达,以测试粘液分泌在小鼠过敏性和感染性肺部炎症模型中的保护和病理生理作用,并分析小鼠和人类中Munc 18 B表达的控制,以深入了解粘液化生的分子发病机制。目的1:进一步表征Munc 18蛋白在小鼠和人细胞中调节气道粘液分泌的细胞生物学。目标二:通过减少Munc 18 B表达,降低气道杯状细胞分泌粘液的能力,分析粘液高分泌在过敏性哮喘和细菌性肺炎小鼠模型中的保护作用和病理生理作用。目标三:确定小鼠气道上皮化生中控制Munc 18 B基因表达的关键顺式作用DNA元件和转录因子。目标4:确认顺式作用DNA元件和转录因子在人类气道分泌性化生中控制Munc 18 B基因表达的重要性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Burton F Dickey其他文献

Burton F Dickey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Burton F Dickey', 18)}}的其他基金

Controlling the core airway mucin secretion machinery to prevent pathophysiology
控制核心气道粘蛋白分泌机制以预防病理生理学
  • 批准号:
    10373980
  • 财政年份:
    2015
  • 资助金额:
    $ 37.63万
  • 项目类别:
Controlling the core airway mucin secretion machinery to prevent pathophysiology
控制核心气道粘蛋白分泌机制以预防病理生理学
  • 批准号:
    10133121
  • 财政年份:
    2015
  • 资助金额:
    $ 37.63万
  • 项目类别:
Controlling the core airway mucin secretion machinery to prevent pathophysiology
控制核心气道粘蛋白分泌机制以预防病理生理学
  • 批准号:
    8985701
  • 财政年份:
    2015
  • 资助金额:
    $ 37.63万
  • 项目类别:
Controlling the core airway mucin secretion machinery to prevent pathophysiology
控制核心气道粘蛋白分泌机制以预防病理生理学
  • 批准号:
    10593182
  • 财政年份:
    2015
  • 资助金额:
    $ 37.63万
  • 项目类别:
Regulation of Mucin Exocytosis by Munc18
Munc18 对粘蛋白胞吐作用的调节
  • 批准号:
    7740020
  • 财政年份:
    2009
  • 资助金额:
    $ 37.63万
  • 项目类别:
Regulation of Mucin Exocytosis by Munc18
Munc18 对粘蛋白胞吐作用的调节
  • 批准号:
    7901030
  • 财政年份:
    2009
  • 资助金额:
    $ 37.63万
  • 项目类别:
Munc18 Proteins in Airway Mucus Hypersecretion
气道粘液分泌过多中的 Munc18 蛋白
  • 批准号:
    6722780
  • 财政年份:
    2003
  • 资助金额:
    $ 37.63万
  • 项目类别:
Munc18 Proteins in Airway Mucus Hypersecretion
气道粘液分泌过多中的 Munc18 蛋白
  • 批准号:
    7101718
  • 财政年份:
    2003
  • 资助金额:
    $ 37.63万
  • 项目类别:
Munc18 Proteins in Airway Mucus Hypersecretion
气道粘液分泌过多中的 Munc18 蛋白
  • 批准号:
    6875625
  • 财政年份:
    2003
  • 资助金额:
    $ 37.63万
  • 项目类别:
Research Training in Lung Disease
肺部疾病研究培训
  • 批准号:
    6593147
  • 财政年份:
    1993
  • 资助金额:
    $ 37.63万
  • 项目类别:

相似海外基金

The Function and Potential Application of Extracellular Vesicle Derived Clara Cell Protein 16 in Gram-negative Bacterial Pneumonia
细胞外囊泡衍生的 Clara 细胞蛋白 16 在革兰氏阴性细菌性肺炎中的功能和潜在应用
  • 批准号:
    10905165
  • 财政年份:
    2023
  • 资助金额:
    $ 37.63万
  • 项目类别:
Follistatin-like 1 Mediated Host Defense in Bacterial Pneumonia
类卵泡抑素 1 介导细菌性肺炎中的宿主防御
  • 批准号:
    10636904
  • 财政年份:
    2022
  • 资助金额:
    $ 37.63万
  • 项目类别:
The vital role of T404 phosphorylation of STAT2 in post-viral bacterial pneumonia
STAT2 T404 磷酸化在病毒后细菌性肺炎中的重要作用
  • 批准号:
    10683783
  • 财政年份:
    2022
  • 资助金额:
    $ 37.63万
  • 项目类别:
Fungal dysbiosis regulation of post-influenza bacterial pneumonia
流感后细菌性肺炎的真菌失调调节
  • 批准号:
    10097806
  • 财政年份:
    2021
  • 资助金额:
    $ 37.63万
  • 项目类别:
Fungal dysbiosis regulation of post-influenza bacterial pneumonia
流感后细菌性肺炎的真菌失调调节
  • 批准号:
    10452478
  • 财政年份:
    2021
  • 资助金额:
    $ 37.63万
  • 项目类别:
Fungal dysbiosis regulation of post-influenza bacterial pneumonia
流感后细菌性肺炎的真菌失调调节
  • 批准号:
    10654630
  • 财政年份:
    2021
  • 资助金额:
    $ 37.63万
  • 项目类别:
Therapeutic Use of High Molecular Weight Hyaluronic Acid in Acute Lung Injury Following Severe Bacterial Pneumonia or Sepsis
高分子量透明质酸在严重细菌性肺炎或脓毒症后急性肺损伤中的治疗用途
  • 批准号:
    10398829
  • 财政年份:
    2020
  • 资助金额:
    $ 37.63万
  • 项目类别:
Functions of TBK1 in neutrophils during bacterial pneumonia
细菌性肺炎期间中性粒细胞中TBK1的功能
  • 批准号:
    10316200
  • 财政年份:
    2020
  • 资助金额:
    $ 37.63万
  • 项目类别:
Therapeutic Use of High Molecular Weight Hyaluronic Acid in Acute Lung Injury Following Severe Bacterial Pneumonia or Sepsis
高分子量透明质酸在严重细菌性肺炎或脓毒症后急性肺损伤中的治疗用途
  • 批准号:
    10614496
  • 财政年份:
    2020
  • 资助金额:
    $ 37.63万
  • 项目类别:
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome
唐氏综合症细菌性肺炎易感性和严重程度的持续病毒感染后状态
  • 批准号:
    9817272
  • 财政年份:
    2019
  • 资助金额:
    $ 37.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了